stearylamine has been researched along with Leishmaniasis, American in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fallah, M; Jaafari, MR; Moosavian, SA | 1 |
| Arantes, VT; Caldeira, LR; de Oliveira, MC; de Oliveira, RB; Egito, ES; Ferreira, LA; Santos, CM | 1 |
2 other study(ies) available for stearylamine and Leishmaniasis, American
| Article | Year |
|---|---|
The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
Topics: Amines; Analysis of Variance; Animals; Antiprotozoal Agents; Female; Leishmania major; Leishmaniasis, Cutaneous; Liposomes; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Rabbits; Spleen | 2019 |
Amphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: development, characterization, and in vitro skin permeation studies.
Topics: Administration, Cutaneous; Amines; Amphotericin B; Analysis of Variance; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Drug Stability; Emulsions; Leishmaniasis, Cutaneous; Nanoparticles; Skin; Skin Absorption; Swine | 2012 |